A detailed history of Alpha Cubed Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Alpha Cubed Investments, LLC holds 8,372 shares of ABBV stock, worth $1.54 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,372
Previous 13,497 37.97%
Holding current value
$1.54 Million
Previous $2.67 Million 44.2%
% of portfolio
0.07%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

SELL
$164.99 - $203.87 $845,573 - $1.04 Million
-5,125 Reduced 37.97%
8,372 $1.49 Million
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $29,818 - $36,278
-182 Reduced 1.33%
13,497 $2.67 Million
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $168,101 - $196,305
1,086 Added 8.62%
13,679 $2.35 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $253,794 - $289,174
1,588 Added 14.43%
12,593 $2.29 Million
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $156,588 - $176,355
-1,138 Reduced 9.37%
11,005 $1.71 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $304,451 - $352,447
2,279 Added 23.1%
12,143 $1.81 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $143,905 - $179,081
-1,086 Reduced 9.92%
9,864 $1.33 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $84,452 - $97,259
584 Added 5.63%
10,950 $1.75 Million
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $139,416 - $167,196
1,008 Added 10.77%
10,366 $0
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $95,825 - $109,906
714 Added 8.26%
9,358 $1.26 Million
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $39,221 - $49,863
285 Added 3.41%
8,644 $1.32 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $1.65 Million - $2.04 Million
-12,473 Reduced 59.87%
8,359 $1.36 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $42,864 - $54,236
399 Added 1.95%
20,832 $2.82 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $169,708 - $192,644
1,595 Added 8.47%
20,433 $2.2 Million
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $19,884 - $22,152
189 Added 1.01%
18,838 $2.12 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $157,542 - $173,434
1,540 Added 9.0%
18,649 $2.02 Million
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $1.17 Million - $1.58 Million
-14,522 Reduced 45.91%
17,109 $1.83 Million
Q3 2020

Oct 14, 2020

SELL
$85.91 - $100.83 $88,143 - $103,451
-1,026 Reduced 3.14%
31,631 $2.77 Million
Q2 2020

Jul 13, 2020

BUY
$73.37 - $98.18 $11,445 - $15,316
156 Added 0.48%
32,657 $3.21 Million
Q1 2020

Apr 10, 2020

BUY
$64.5 - $97.79 $35,088 - $53,197
544 Added 1.7%
32,501 $2.48 Million
Q4 2019

Jan 17, 2020

SELL
$72.13 - $90.25 $14,930 - $18,681
-207 Reduced 0.64%
31,957 $2.83 Million
Q3 2019

Oct 18, 2019

SELL
$62.98 - $75.72 $4,597 - $5,527
-73 Reduced 0.23%
32,164 $2.44 Million
Q2 2019

Jul 19, 2019

BUY
$65.7 - $83.98 $18,133 - $23,178
276 Added 0.86%
32,237 $2.34 Million
Q1 2019

Apr 26, 2019

SELL
$77.14 - $90.79 $197,709 - $232,694
-2,563 Reduced 7.42%
31,961 $2.58 Million
Q4 2018

Jan 29, 2019

SELL
$77.85 - $96.01 $33,086 - $40,804
-425 Reduced 1.22%
34,524 $3.18 Million
Q3 2018

Oct 25, 2018

SELL
$88.91 - $98.84 $111,226 - $123,648
-1,251 Reduced 3.46%
34,949 $3.07 Million
Q2 2018

Jul 26, 2018

SELL
$89.78 - $106.23 $326,350 - $386,146
-3,635 Reduced 9.13%
36,200 $3.35 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $237,845 - $318,497
-2,585 Reduced 6.09%
39,835 $3.77 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $649,310 - $712,022
-7,250 Reduced 14.6%
42,420 $4.1 Million
Q3 2017

Oct 23, 2017

BUY
$69.85 - $89.22 $3.47 Million - $4.43 Million
49,670
49,670 $4.41 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alpha Cubed Investments, LLC Portfolio

Follow Alpha Cubed Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.